An unstable variant of GAP43 leads to neurodevelopmental deficiency

Abstract Growth-associated protein 43 (GAP43) is a membrane-associated phosphoprotein predominantly expressed in the nervous systems, and controls axonal growth, branching, and pathfinding. While the association between GAP43 and human neurological disorders have been reported, the underlying mechan...

Full description

Saved in:
Bibliographic Details
Main Authors: Mariko Noda, Ayumi Matsumoto, Hidenori Ito, Masayo Kagami, Toshihiro Tajima, Takayoshi Matsumura, Takanori Yamagata, Koh-ichi Nagata
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-83445-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559466010476544
author Mariko Noda
Ayumi Matsumoto
Hidenori Ito
Masayo Kagami
Toshihiro Tajima
Takayoshi Matsumura
Takanori Yamagata
Koh-ichi Nagata
author_facet Mariko Noda
Ayumi Matsumoto
Hidenori Ito
Masayo Kagami
Toshihiro Tajima
Takayoshi Matsumura
Takanori Yamagata
Koh-ichi Nagata
author_sort Mariko Noda
collection DOAJ
description Abstract Growth-associated protein 43 (GAP43) is a membrane-associated phosphoprotein predominantly expressed in the nervous systems, and controls axonal growth, branching, and pathfinding. While the association between GAP43 and human neurological disorders have been reported, the underlying mechanisms remain largely unknown. We performed whole exome sequencing on a patient with intellectual disability (ID), neurodevelopmental disorders, short stature, and skeletal abnormalities such as left–right difference in legs and digital deformities, and identified a heterozygous missense variation in the GAP43 gene [NM_001130064.2: c.436G > A/p.(E146K)]. The variant GAP43 protein was unstable in primary cultured cortical neurons and hippocampal neurons in vitro. In utero electroporation of the variant protein also confirmed its instability in vivo, suggesting that the variant led to a condition similar with haploinsufficiency in the patient. Silencing of GAP43 via in utero electroporation of RNAi vectors demonstrated that loss of GAP43 suppressed axon elongation into the contralateral hemisphere and impaired the dendritic arbor formation as shown by decreased dendritic branch points and shortened total dendritic lengths. Collectively, these findings confirmed the critical roles of GAP43 in brain development and the pathological basis of GAP43-associated diseases. Our study will contribute to a better understanding of how dysregulation of GAP43 leads to human diseases.
format Article
id doaj-art-c8c5c6f1e35b400e91a7af0c962b0dde
institution Kabale University
issn 2045-2322
language English
publishDate 2024-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-c8c5c6f1e35b400e91a7af0c962b0dde2025-01-05T12:30:11ZengNature PortfolioScientific Reports2045-23222024-12-0114111210.1038/s41598-024-83445-wAn unstable variant of GAP43 leads to neurodevelopmental deficiencyMariko Noda0Ayumi Matsumoto1Hidenori Ito2Masayo Kagami3Toshihiro Tajima4Takayoshi Matsumura5Takanori Yamagata6Koh-ichi Nagata7Department of Molecular Neurobiology, Institute for Developmental Research, Aichi Developmental Disability CenterDepartment of Pediatrics, Jichi Medical UniversityDepartment of Molecular Neurobiology, Institute for Developmental Research, Aichi Developmental Disability CenterClinical Endocrine Research Division, Department of Molecular Endocrinology, National Research Institute for Child Health and DevelopmentDepartment of Pediatrics, Jichi Medical UniversityDivision of Cardiovascular and Genetic Research, Center for Molecular Medicine, Jichi Medical UniversityDepartment of Pediatrics, Jichi Medical UniversityDepartment of Molecular Neurobiology, Institute for Developmental Research, Aichi Developmental Disability CenterAbstract Growth-associated protein 43 (GAP43) is a membrane-associated phosphoprotein predominantly expressed in the nervous systems, and controls axonal growth, branching, and pathfinding. While the association between GAP43 and human neurological disorders have been reported, the underlying mechanisms remain largely unknown. We performed whole exome sequencing on a patient with intellectual disability (ID), neurodevelopmental disorders, short stature, and skeletal abnormalities such as left–right difference in legs and digital deformities, and identified a heterozygous missense variation in the GAP43 gene [NM_001130064.2: c.436G > A/p.(E146K)]. The variant GAP43 protein was unstable in primary cultured cortical neurons and hippocampal neurons in vitro. In utero electroporation of the variant protein also confirmed its instability in vivo, suggesting that the variant led to a condition similar with haploinsufficiency in the patient. Silencing of GAP43 via in utero electroporation of RNAi vectors demonstrated that loss of GAP43 suppressed axon elongation into the contralateral hemisphere and impaired the dendritic arbor formation as shown by decreased dendritic branch points and shortened total dendritic lengths. Collectively, these findings confirmed the critical roles of GAP43 in brain development and the pathological basis of GAP43-associated diseases. Our study will contribute to a better understanding of how dysregulation of GAP43 leads to human diseases.https://doi.org/10.1038/s41598-024-83445-w
spellingShingle Mariko Noda
Ayumi Matsumoto
Hidenori Ito
Masayo Kagami
Toshihiro Tajima
Takayoshi Matsumura
Takanori Yamagata
Koh-ichi Nagata
An unstable variant of GAP43 leads to neurodevelopmental deficiency
Scientific Reports
title An unstable variant of GAP43 leads to neurodevelopmental deficiency
title_full An unstable variant of GAP43 leads to neurodevelopmental deficiency
title_fullStr An unstable variant of GAP43 leads to neurodevelopmental deficiency
title_full_unstemmed An unstable variant of GAP43 leads to neurodevelopmental deficiency
title_short An unstable variant of GAP43 leads to neurodevelopmental deficiency
title_sort unstable variant of gap43 leads to neurodevelopmental deficiency
url https://doi.org/10.1038/s41598-024-83445-w
work_keys_str_mv AT marikonoda anunstablevariantofgap43leadstoneurodevelopmentaldeficiency
AT ayumimatsumoto anunstablevariantofgap43leadstoneurodevelopmentaldeficiency
AT hidenoriito anunstablevariantofgap43leadstoneurodevelopmentaldeficiency
AT masayokagami anunstablevariantofgap43leadstoneurodevelopmentaldeficiency
AT toshihirotajima anunstablevariantofgap43leadstoneurodevelopmentaldeficiency
AT takayoshimatsumura anunstablevariantofgap43leadstoneurodevelopmentaldeficiency
AT takanoriyamagata anunstablevariantofgap43leadstoneurodevelopmentaldeficiency
AT kohichinagata anunstablevariantofgap43leadstoneurodevelopmentaldeficiency
AT marikonoda unstablevariantofgap43leadstoneurodevelopmentaldeficiency
AT ayumimatsumoto unstablevariantofgap43leadstoneurodevelopmentaldeficiency
AT hidenoriito unstablevariantofgap43leadstoneurodevelopmentaldeficiency
AT masayokagami unstablevariantofgap43leadstoneurodevelopmentaldeficiency
AT toshihirotajima unstablevariantofgap43leadstoneurodevelopmentaldeficiency
AT takayoshimatsumura unstablevariantofgap43leadstoneurodevelopmentaldeficiency
AT takanoriyamagata unstablevariantofgap43leadstoneurodevelopmentaldeficiency
AT kohichinagata unstablevariantofgap43leadstoneurodevelopmentaldeficiency